Okabe, Takafumi
Broad Institute · Brigham and Women's Hospital · Harvard University · Samsung Medical Center · Dana-Farber Cancer Institute
2 papers on CoChat
Most cited papers
- Verified
Activation of ERBB2 signaling causes resistance to the EGFR-directed therapeutic antibody cetuximab
Yonesaka, K., Zejnullahu, K., Okamoto, I., Satoh, T., Cappuzzo, F., Souglakos, J., Ercan, D., Rogers, A., Roncalli, M., Takeda, M., et al. (2011) · Science Translational Medicine
HER2/EGFR in Cancer ResearchColorectal Cancer Treatments and Studies
Cited by 663
- Verified
Cetuximab response of lung cancer-derived EGF receptor mutants is associated with asymmetric dimerization
Cho, J., Chen, L., Sangji, N., Okabe, T., Yonesaka, K., Francis, J. M., Flavin, R. J., Johnson, W., Kwon, J., Yu, S., et al. (2013) · Cancer Research
Lung Cancer Treatments and MutationsHER2/EGFR in Cancer Research
Cited by 117
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free